The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index; 32 of the 45 sources its claims cite were checked for support.
mHealth low carbohydrate dietary intervention ameliorates glycaemic profile, blood pressure and weight status in people with type 2 diabetes
Open accessAbstract
Low carbohydrate diets (LCD) have shown efficacy in managing clinical outcomes in type 2 diabetes (T2D). Incorporating digital tools into health care provides an adjunct treatment modality, to educate patients and provide clinical support. This study examines the effect of a mobile health (mHealth) LCD application (app) on glycaemic profile, blood pressure and weight status, in people with T2D. The study is an online single-arm, pre-post study that recruited people with T2D from around Australia, referred via registered supporting general practitioners (GPs). The intervention (Defeat Diabetes app) provides education and resources on the use of a LCD for ongoing management of T2D. After 3 months, our cohort of 99 participants (mean age 59 ± 11 years, 55 females) showed reduced dietary carbohydrate intake as a proportion of overall energy (−14%kJ/day, 95% CI: −17 to −11). Improvement in the primary outcome HbA1c (−1.0%, 95% CI: −1.3 to −0.7), was associated with reduction in dietary carbohydrate intake. Systolic blood pressure (SBP) improved (−6 mmHg, 95% CI: −10 to −1), while 21 participants reduced their diabetes medication dose with two participants discontinuing all diabetes medication. These findings demonstrate that people with T2D receiving LCD education and resources through the Defeat Diabetes app for 3 months improved their glycaemic profile and SBP despite decreased overall medication usage in almost one third of the study sample prescribed medication at baseline.
Overview
CoChat Summary
TL;DR
In an online single-arm pre-post study of 99 Australian adults with type 2 diabetes, a mobile health low-carbohydrate app intervention was associated with improved glycaemic control, systolic blood pressure, and dietary carbohydrate reduction after 3 months. The authors conclude the Defeat Diabetes app may be a useful additional tool for lifestyle management of T2D.
Key findings
- After 3 months, HbA1c decreased by −1.0% (95% CI: −1.3 to −0.7) and fasting plasma glucose by −1.3 mmol/L (95% CI: −2.1 to −0.6); 52% of participants reduced HbA1c to below 6.5%.
- Dietary carbohydrate intake fell by −14% kJ/day (95% CI: −17 to −11), total energy intake fell by −1570 kJ/day (95% CI: −2128 to −1013), protein increased by 6% kJ/day (95% CI: 4–7), and total fat increased by 9% kJ/day (95% CI: 6–11).
- Systolic blood pressure decreased by −6 mmHg (95% CI: −10 to −1); no significant changes were found in diastolic blood pressure, waist circumference, body weight, or BMI.
- Medication changes: 21 participants reduced their diabetes medication dose and 2 discontinued all diabetes medication; 5 reduced hypertension medication dose and 3 discontinued all hypertension medications.
Methods
- Online single-arm, pre-post study following participants over 12 months, reporting 3-month outcomes; participants with T2D were recruited from around Australia via registered supporting GPs, with data collected October 2022 to May 2024.
- The intervention was the Defeat Diabetes app, a subscription-based mHealth program providing low-carbohydrate education, recipes, meal plans, food lists, exercise plans, and optional peer support; n = 99 participants (55 females; mean age 58.4 ± 11.3 years in Table 1).
- Primary outcome was change in HbA1c from GP-provided REDCap data; secondary outcomes included FPG, blood pressure, anthropometrics, and medication use. Dietary intake was assessed by 3-day food records or 24-h recalls, physical activity by IPAQ, and analyses used univariate linear regression adjusted for sex, age, time since diagnosis, co-existing conditions, and dietary carbohydrate reduction, plus Chi-square tests for categorical variables.
Limitations
- Stated: no control group; food records may not reflect eating behaviour over the whole intervention and some participants had already reduced carbohydrate intake before consent; digital competence was not assessed; not all participants used Facebook for peer support; GP referral meant the number of non-participants was unknown; missing data occurred for bloodwork, blood pressure, weight, and waist circumference; and no standardised procedures were used for anthropometry or blood pressure measurement.
- Stated: small sample size limited gender comparisons, and the cohort had a smaller proportion of males and longer median diabetes duration in females, which may explain lesser HbA1c reductions in females.
- Evident from the design: the single-arm pre-post design cannot establish causality, and the 3-month follow-up cannot show longer-term sustainability or remission.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
17 Valid · 3 Not valid · 2 Not checked · 76 Own results and interpretations
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“This may explain why the females in the cohort had lesser reductions in HbA1c when compared to males31.”
§ mHealth low carbohydrate dietary intervention ameliorates glycaemic profile, blood pressure and weight status in people with type 2 diabetes > Discussion
What the sources say
- Could not verifycites [31] Lean, M. E. et al. Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial. Lancet 391, 541–551 (2018). sourceExperimental — accuracy not yet measured
The supplementary subgroup table in the copy (displayed under References; page unavailable) reports diabetes remission by sex and by duration since diagnosis, but not HbA1c reductions by sex. Searches for sex-specific HbA1c changes and a link between diagnosis duration and female–male differences found no passage addressing the proposed explanation. (LLM, conf=0.72)
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“In addition, there is evidence indicating that LCD increases the likelihood of “T2D remission”, which is defined as maintaining “HbA1c < 6.5% measured at least 3 months after cessation of glucose-lowering pharmacotherapy,” and of “T2D reversal”, a term used to describe the return of blood glucose levels to below the threshold diagnostic of diabetes, whilst on metformin11,12.”
§ mHealth low carbohydrate dietary intervention ameliorates glycaemic profile, blood pressure and weight status in people with type 2 diabetes > Introduction
What the sources say
- Partly supportedcites [11] Riddle, M. C. et al. Consensus Report: Definition and Interpretation of Remission in Type 2 Diabetes. J. Clin. Endocrinol. Metab. 107, 1–9 (2022). sourceExperimental — accuracy not yet measured
The Conclusions define T2D remission as HbA1c <6.5% persisting for at least three months without usual glucose-lowering pharmacotherapy. The paper discusses remission after lifestyle changes, but the passages do not establish that LCD specifically increases its likelihood. (LLM, conf=0.88)
- Partly supportedcites [12] Goldenberg, J. Z. et al. Efficacy and safety of low and very low carbohydrate diets for type 2 diabetes remission: systematic review and meta-analysis of published and unpublished randomized trial data. BMJ, m4743 https://doi.org/10.1136/bmj.m4743 (2021). sourceExperimental — accuracy not yet measured
The Results report that LCDs increased remission at six months when remission meant HbA1c below 6.5% regardless of medication use. For remission requiring no diabetes medication, the estimated increase was smaller and its confidence interval included no effect. The paper does not define remission as HbA1c below 6.5% measured at least three months after stopping medication; its Methods allow remission with or without medication. (LLM, conf=0.88)
hedgedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Similarly, a systematic literature review examining technology-enabled LCD or VLCKD interventions identified five studies that reported significant reductions in mean HbA1c (ranging from −0.4% to −1.3%) and weight loss (ranging from −3.8 kg to −14 kg) for up to two years18.”
§ mHealth low carbohydrate dietary intervention ameliorates glycaemic profile, blood pressure and weight status in people with type 2 diabetes > Introduction
What the sources say
- Supportedcites [18] Jooste, B. R., Kolivas, D., Brukner, P. & Moschonis, G. Effectiveness of Technology-Enabled, Low Carbohydrate Dietary Interventions, in the Prevention or Treatment of Type 2 Diabetes Mellitus in Adults: A Systematic Literature Review of Randomised Controlled and Non-Randomised Trials. Nutrients 15, 4362 (2023). source
The Discussion (§4.1) reports that three digitally delivered VLCD studies found weight reductions of −12 to −14 kg over up to two years, while two LCD studies found reductions of −3.8 to −7.5 kg at one year. Together, those five studies support the stated overall range and duration. (LLM, conf=0.94)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Similarly, a systematic literature review examining technology-enabled LCD or VLCKD interventions identified five studies that reported significant reductions in mean HbA1c (ranging from −0.4% to −1.3%) and weight loss (ranging from −3.8 kg to −14 kg) for up to two years18.”
§ mHealth low carbohydrate dietary intervention ameliorates glycaemic profile, blood pressure and weight status in people with type 2 diabetes > Introduction
What the sources say
- Supportedcites [18] Jooste, B. R., Kolivas, D., Brukner, P. & Moschonis, G. Effectiveness of Technology-Enabled, Low Carbohydrate Dietary Interventions, in the Prevention or Treatment of Type 2 Diabetes Mellitus in Adults: A Systematic Literature Review of Randomised Controlled and Non-Randomised Trials. Nutrients 15, 4362 (2023). source
The Discussion (§4.1; page not available) reports HbA1c reductions of −0.8% to −1.3% in three technology-enabled VLCD studies and −0.4% to −1.2% in two LCD studies. Together, these five studies give the claimed −0.4% to −1.3% range; the section also reports the cited weight-loss ranges and follow-up of up to two years. (LLM, conf=0.93)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Research evidence shows that the prescription of a low carbohydrate diet (LCD) for management of T2D improves glycaemic control, reduces the need for medications, assists with weight loss, and may improve blood lipid concentrations5–9.”
§ mHealth low carbohydrate dietary intervention ameliorates glycaemic profile, blood pressure and weight status in people with type 2 diabetes > Introduction
What the sources say
- Partly supportedcites [5] Snorgaard, O., Poulsen, G. M., Andersen, H. K. & Astrup, A. Systematic review and meta-analysis of dietary carbohydrate restriction in patients with type 2 diabetes. BMJ Open Diab. Res. Care 5, e000354 (2017). sourceExperimental — accuracy not yet measured
The Results (Effects of the intervention; page not provided) report that low- and high-carbohydrate diets had equal effects on body weight and BMI in people with type 2 diabetes. The paper does not establish that prescribing a low-carbohydrate diet produces weight loss in absolute terms; it establishes no weight-loss advantage over a high-carbohydrate diet. This does not contradict the narrower possibility that both diets assist with weight loss. (LLM, conf=0.72)
- Partly supportedcites [6] Soltani, S. et al. Effect of carbohydrate restriction on body weight in overweight and obese adults: a systematic review and dose–response meta-analysis of 110 randomized controlled trials. Front. Nutr. 10, 1287987 (2023). sourceExperimental — accuracy not yet measured
The Conclusion reports clinically important weight loss with carbohydrate-restricted diets at 6 and 12 months. However, the review studied adults with overweight or obesity regardless of health status; it does not establish the weight-loss effect specifically for diets prescribed to manage T2D. (LLM, conf=0.84)
- Supportedcites [7] Rock, C. L. et al. Weight Loss, Glycemic Control, and Cardiovascular Disease Risk Factors in Response to Differential Diet Composition in a Weight Loss Program in Type 2 Diabetes: A Randomized Controlled Trial. Diab. Care 37, 1573–1580 (2014). source
The Results report that participants with type 2 diabetes assigned to the lower-carbohydrate weight-loss program lost 9.0% of their initial weight at 12 months, compared with 2.5% in usual care. The diet was part of a broader program, and the paper found no significant weight-loss difference between the lower- and higher-carbohydrate program groups in the intention-to-treat analysis. (LLM, conf=0.90)
- Not checked — no full text of the sourcecites [8] Tay, J. et al. Comparison of low- and high-carbohydrate diets for type 2 diabetes management: a randomized trial. Am. J. Clin. Nutr. 102, 780–790 (2015). source
- Not checked — no full text of the sourcecites [9] Feinman, R. D. et al. Dietary carbohydrate restriction as the first approach in diabetes management: Critical review and evidence base. Nutrition 31, 1–13 (2015). source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
45 more claims · 7 with their cited sources checked
Create a free account to see all 98 claims and every source verdict.
- Probably not a substantial claim. 27
- It may state two separate claims as one. 32
- The quote only partly states this claim. 1
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
“| Total sample | 99 | 83 | 11 | 92 | 80 | 11 | 2 | −5 | 1 | 0.168 |”
§ mHealth low carbohydrate dietary intervention ameliorates glycaemic profile, blood pressure and weight status in people with type 2 diabetes > Results > Changes in clinical outcomes
Reported 2 · recomputed -3
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ mHealth low carbohydrate dietary intervention ameliorates glycaemic profile, blood pressure and weight status in people with type 2 diabetes > Results > Changes in clinical outcomes
“The changes in HbA1c were more pronounced in males (−1.2%, 95% CI: −1.7 to −0.7) compared to females (−0.8 mmol/l, 95% CI: −1.2 to −0.4).”
§ mHealth low carbohydrate dietary intervention ameliorates glycaemic profile, blood pressure and weight status in people with type 2 diabetes > Results > Changes in clinical outcomes
“| HbA1c % | HbA1c % | HbA1c % | HbA1c % | HbA1c % | HbA1c % | HbA1c % | HbA1c % | HbA1c % | HbA1c % |”
Citations
Cites
Harris, P. A., Taylor, R., Thielke, R., Payne, J., Gonzalez, N., & Conde, J. G. (2009) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2008.08.010 · Cited by 51,384
The REDCap consortium: building an international community of software platform partners
Harris, P. A., Taylor, R., Minor, B. L., Elliott, V., Fernandez, M., O'Neal, L., McLeod, L., Delacqua, G., Delacqua, F., Kirby, J., et al. (2019) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2019.103208 · Cited by 24,013 · cited 1×
“Data collection was facilitated by online Research electronic data capture (REDCap) case report forms (CRFs) sent via email to GPs and participants 20,21 .”
International Diabetes Federation 2017
Carracher, A. M., Marathe, P. H., & Close, K. L. (2018) · Journal of Diabetes · doi:10.1111/1753-0407.12644 · Cited by 13,418
Stratton, I. M. (2000) · BMJ · doi:10.1136/bmj.321.7258.405 · Cited by 9,059 · cited 1×
“Poor glycaemic control, as indicated by increased levels of glycosylated hemoglobin (HbA1c), is associated with increased risk of developing T2D complications over time and places an increasing cost and resource burden on health care systems, presenting a growing challenge for public health 3 .”
Ong, K. L., Stafford, L. K., McLaughlin, S. A., Boyko, E. J., Vollset, S. E., Smith, A. E., Dalton, B. E., Duprey, J., Cruz, J. A., Hagins, H., et al. (2023) · The Lancet · doi:10.1016/s0140-6736(23)01301-6 · Cited by 6,146
Lee, P. H., Macfarlane, D. J., Lam, T., & Stewart, S. M. (2011) · International Journal of Behavioral Nutrition and Physical Activity · doi:10.1186/1479-5868-8-115 · Cited by 3,370 · cited 4×
“It should also be noted that there was no signi fi cant change to physical activity levels as determined by the IPAQ questionnaire.”
InfluentialBauer, J., Biolo, G., Cederholm, T., Cesari, M., Cruz-Jentoft, A. J., Morley, J. E., Phillips, S., Sieber, C., Stehle, P., Teta, D., et al. (2013) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2013.05.021 · Cited by 2,553
Lean, M. E., Leslie, W. S., Barnes, A. C., Brosnahan, N., Thom, G., McCombie, L., Peters, C., Zhyzhneuskaya, S., Al-Mrabeh, A., Hollingsworth, K. G., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(17)33102-1 · Cited by 2,095 · cited 3×
“The UK DiRECT study, as well as the DiRECT-Aus trial provide evidence that remission is possible with sustained weight loss maintenance, with 68 out of 138 people, and 86 out of 155 people in the intervention group achieving remission at 12 months in each respective cohort 31,37 .”
THE ROYAL AUSTRALIAN COLLEGE OF GENERAL PRACTITIONERS
(1974) · Medical Journal of Australia · doi:10.5694/j.1326-5377.1974.tb93279.x · Cited by 1,341
Feinman, R. D., Pogozelski, W. K., Astrup, A., Bernstein, R. K., Fine, E. J., Westman, E. C., Accurso, A., Frassetto, L., Gower, B. A., McFarlane, S. I., et al. (2015) · Nutrition · doi:10.1016/j.nut.2014.06.011 · Cited by 912
Cited by
Kolivas, D., Fraser, L., Schweitzer, R., Brukner, P. D., & Moschonis, G. (2026) · International Journal of Behavioral Medicine · doi:10.1007/s12529-026-10447-5 · Cited by 1
“As reported else-where, we found that there was a significant improvement in HbA1c after 3 months of using the Defeat Diabetes app and, on average, the amount of dietary carbohydrate consumed by study participants decreased significantly as did overall dietary energy intake [30].”
InfluentialSelf-citationCHOctrl: A Culturally Contextualized Digital Intervention for Carbohydrate Portion Control in China
Meng, Y., & Bei, R. (2026) · Lecture notes of the Institute for Computer Sciences, Social Informatics and Telecommunications Engineering · doi:10.1007/978-3-032-27582-0_29
Kolivas, D., & Moschonis, G. (2026) · Nutrients · doi:10.3390/nu18071115
“Finally, we acknowledge the inherent limitations in dietary data collection and reporting [3,4].”
Self-citationKolivas, D., & Moschonis, G. (2026) · npj Metabolic Health and Disease · doi:10.1038/s44324-026-00104-6
Self-citation
Metadata
- Authors
- Kolivas, D., Fraser, L., Schweitzer, R., Brukner, P., & Moschonis, G.
- Affiliations
- La Trobe University (AU)
- Monash University (AU)
- Corresponding author
- Kolivas, Despina
- Moschonis, George
- Venue
- npj Metabolic Health and Disease
- Published
- 2025-04-08
- Volume
- 3
- Issue
- 1
- Pages
- 12-12
- ISSN
- 2948-2828 (ISSN-L)
- PMC
- PMC12118682
- OpenAlex
- W4409266593
- Cited by
- 7
- References
- 33
- Citations by year
- 2026: 6 · 2025: 1
- FWCI
- 4.50
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- npj Metabolic Health and Disease (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- La Trobe University Industry Funded Research Scholarship in conjunction with Defeat Diabetes
- La Trobe University
- Topics
- Health Sciences › Medicine › Physiology (medical) › Diet and metabolism studies
- Health Sciences › Health Professions › General Health Professions › Mobile Health and mHealth Applications
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- type 2 diabetes, low-carbohydrate diet, mobile health, glycemic control, HbA1c, systolic blood pressure, weight status, carbohydrate intake, diabetes medication reduction, patient education
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: mHealth low carbohydrate dietary intervention ameliorates glycaemic profile, blood pressure and weight status in people with type 2 diabetes. https://app.cochat.ai/papers/10.1038/s44324-025-00053-6
- The paper
- Kolivas, D., Fraser, L., Schweitzer, R., Brukner, P., & Moschonis, G. (2025). mHealth low carbohydrate dietary intervention ameliorates glycaemic profile, blood pressure and weight status in people with type 2 diabetes. npj Metabolic Health and Disease. https://doi.org/10.1038/s44324-025-00053-6
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.